Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
Journal of Affective Disorders|January 11, 2016
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-ReportNoreen A Reilly-Harrington, Richard C Shelton, Masoud Kamali, et al.
The Journal of Clinical Psychiatry|February 5, 2016
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE studyThilo Deckersbach, Andrew A Nierenberg, Melvin G McInnis, et al.
Journal of Affective Disorders|December 24, 2018
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scaleGustavo Kinrys, Charles L Bowden, Andrew A Nierenberg, et al.
Bipolar Disorders|August 19, 2014
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)Louisa G Sylvia, Richard C Shelton, David E Kemp, et al.
Journal of Clinical Psychopharmacology|December 17, 2014
Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE studyWilliam V Bobo, Noreen A Reilly-Harrington, Terence A Ketter, et al.
Journal of Affective Disorders|April 23, 2014
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trialWilliam V Bobo, Noreen A Reilly-Harrington, Terence A Ketter, et al.
Bipolar Disorders|June 18, 2026
Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus ReportRalph Kupka, Danella Hafeman, Madeleine McCallum, et al.
The Journal of Clinical Psychiatry|February 5, 2016
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorderAndrew A Nierenberg, Susan L McElroy, Edward S Friedman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
Bipolar Disorders|August 14, 2025
Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task ForceEduard Vieta, Roger S McIntyre, Trisha Suppes, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Journal of Affective Disorders|January 11, 2016
A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-ReportNoreen A Reilly-Harrington, Richard C Shelton, Masoud Kamali, et al.
The Journal of Clinical Psychiatry|February 5, 2016
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE studyThilo Deckersbach, Andrew A Nierenberg, Melvin G McInnis, et al.
Journal of Affective Disorders|December 24, 2018
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scaleGustavo Kinrys, Charles L Bowden, Andrew A Nierenberg, et al.
Bipolar Disorders|August 19, 2014
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)Louisa G Sylvia, Richard C Shelton, David E Kemp, et al.
Journal of Clinical Psychopharmacology|December 17, 2014
Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE studyWilliam V Bobo, Noreen A Reilly-Harrington, Terence A Ketter, et al.
Journal of Affective Disorders|April 23, 2014
Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trialWilliam V Bobo, Noreen A Reilly-Harrington, Terence A Ketter, et al.
Bipolar Disorders|June 18, 2026
Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus ReportRalph Kupka, Danella Hafeman, Madeleine McCallum, et al.
The Journal of Clinical Psychiatry|February 5, 2016
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorderAndrew A Nierenberg, Susan L McElroy, Edward S Friedman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
Bipolar Disorders|August 14, 2025
Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task ForceEduard Vieta, Roger S McIntyre, Trisha Suppes, et al.
Pageof 26